Nausea, Pain, Pruritus, Vertigo
Conditions
Keywords
tramadol, shoulder surgery, pain, interscalen block, BUPRENORPHINE/HYDROMORPHONE [VA Drug Interaction]
Brief summary
The investigators hypothesize that the use of tramadol will reduce pain and analgesic consumption after arthroscopic shoulder surgery.
Detailed description
The purpose of the study was to evaluate the efficacy of tramadol long acting for post operative pain in patients who had an arthroscopic shoulder surgery in ambulatory setting in comparison with a placebo. The intensity of pain was evaluated on a visual analog scale as the quantity of hydromorphone taken by patients, and the side effects during the first 72 hours.
Interventions
DRUGtramadol
Patients from tramadol group received tramadol 100 mg day one, 100 mg day 2, and 200 mg day 3
DRUGPlacebo
Patients from control group received a shame tramadol pill on day one, two, and 3
Sponsors
Centre hospitalier de l'Université de Montréal (CHUM)
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
* aged more than 18 year old * arthroscopic shoulder surgery on interscalen block * able to understand the protocol * inform consent signed
Exclusion criteria
* chronic pain or chronic used of narcotics * Use of IMAO * Use of ISRS * Pulmonary chronic disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| quantity of hydromorphone consumed | 3 days | determination of the quantity of hydromorphone consumed at different laps |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| evaluation of pain (The intensity of pain was evaluated on a visual analog scale) | 3 days | evaluation of the pain at different laps |
Other
| Measure | Time frame |
|---|---|
| nausea | 3 days |
| dizziness | 3 days |
| pruritus | 3 days |
Countries
Canada
Outcome results
None listed